Sessioni Poster


Pharmacogenetics, pharmacogenomics and gene therapy

Thursday, October 26th / 19.00-21.00
80CONVERGENT ANALYSIS OF GENOME-WIDE GENOTYPING AND TRANSCRIPTOMIC DATA SUGGESTS ASSOCIATION OF ZINC FINGER GENES WITH LITHIUM RESPONSE IN BIPOLAR DISORDER
Pisanu C., Congiu D., Costa M., Chillotti C., Ardau R., Severino G., Angius A., Heilbronner U., Hou L., Mcmahon FJ., Schulze TG., Del Zompo M., Squassina A.
116Tacrolimus Therapeutic Drug Monitoring in Stable Kidney Transplantations and Individuations of CYP3A5 Genotype
Allegri L., Baldan F., Groppuzzo M., Vallone C., Tulissi P., Montanaro G., Damante G., Baraldo M.
123The ABCB1 pharmacogenetics of R-CHOP regimen in mantle cell lymphoma patients: a substudy from the FIL MCL-0208 trial
Arrigoni E., Ferrero S., Zaccaria GM., Lo schirico M., Ciabatti E., Petrini M., Cortelazzo S., Evangelista A., Palumbo G., Ladetto M., Danesi R., Galimberti S., Di paolo A.
174The pharmacogenetics of the response to triptans in patients affected by migraine without aura
Cargnin S., Viana M., Sances G., Tassorelli C., Canonico PL., Genazzani AA., Terrazzino S.
176Role of miR-34a as biomarker and therapeutic agent in cutaneous melanoma
Carpi S., Polini B., Romanini A., Fogli S., Ylösmäki E., Capasso C., Breschi MC., Cerullo V., Nieri P.
213DETECTION OF AR-V7 IN PLASMA-DERIVED EXOSOMAL RNA IN METASTATIC PROSTATE CANCER PATIENTS TREATED WITH FIRST-LINE HORMONAL THERAPY
Crucitta S., Del re M., Biasco E., Rofi E., Galli L., Falcone A., Danesi R.
276INDOMETHACIN INHIBITS PROLIFERATION IN CELLS HARBOURING PIK3CA MUTATIONS
Gallicchio M., Lolli M., Spyrakis F., Bonanni D., Boscaro V.
298LIQUID BIOPSY: A REAL CLINICAL PRACTICE
Iacobelli C., Rofi E., Del re M., Pino MS., Pozzessere D., Belluomini L., Frassoldati A., Iannopollo M., Di lieto M., Danesi R.
315Pharmacoepigenomic markers involved in glucocorticoid response in children with inflammatory bowel disease
Lucafo' M., De iudicibus S., Di Silvestre A., Martelossi S., Naviglio S., Ventura A., Stocco G., Decorti G.
396Monitoring of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitizing and resistance mutations in the plasma DNA of patients with advanced Non-Small Cell Lung Cancer
Restante G.., Rofi E.., Del re M.., Bordi P.., Tiseo M.., Danesi R..
403EARLY VARIATIONS OF KRAS MUTATIONS IN CIRCULATING CELL-FREE TUMOR DNA: A PROMISING BIOMARKER TO MONITOR CHEMOTHERAPY RESISTANCE IN PANCREATIC CANCER
Rofi E., Vivaldi C., Del Re M., Fornaro L., Vasile E., Falcone A., Danesi R.
413DNA METHYLATION: GENE PROFILING IN A CHRONIC MYELOID LEUKEMIA CELL LINE RESISTANT MODEL
Sammarini G., Ravegnini G., Moran S., Esteller M., Hrelia P., Angelini S.